Bank of America Corp DE Sells 1,659,939 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Bank of America Corp DE trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 62.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,018,134 shares of the company's stock after selling 1,659,939 shares during the period. Bank of America Corp DE owned about 0.60% of Option Care Health worth $23,621,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after acquiring an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its holdings in Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after acquiring an additional 591,042 shares in the last quarter. Northern Trust Corp grew its holdings in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after acquiring an additional 278,158 shares in the last quarter. Finally, Norges Bank acquired a new position in Option Care Health during the 4th quarter worth approximately $60,219,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $35.50.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

OPCH stock traded down $0.62 on Friday, hitting $31.41. The company's stock had a trading volume of 836,498 shares, compared to its average volume of 1,862,931. The firm has a 50 day moving average of $32.99 and a two-hundred day moving average of $29.34. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock has a market cap of $5.14 billion, a price-to-earnings ratio of 26.39, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the firm earned $0.26 EPS. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. Equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.